Visitor Monitoring Drug History: RELENZA
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: RELENZA
FDA Application No: (NDA) 021036
Active Ingredient(s): ZANAMIVIR
Company: GLAXOSMITHKLINE
 
Label History
 
View the label approved on September 11, 2007 for RELENZA, (NDA) 021036


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
3/9/2007 013Labeling Revision Letter 
9/7/2007 012Labeling Revision Letter
Label 
3/29/2006 008New or Modified Indication Letter
Label 
8/6/2003 006Labeling Revision Letter
Label 
8/5/2003 005Labeling Revision Letter
Label 
4/27/2001 004Labeling Revision Label
Other Important Information from FDA 
5/18/2001 003Control Supplement  
4/26/2000 001New or Modified Indication Letter
Label
Review 
7/26/1999 000Approval Letter
Label
Review
Consumer Information Sheet 
 
There are no Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test